IPO GMP Surge: Amanta Healthcare, Vikran Engg, Anlon Healthcare Draw Strong Investor Buzz
The charm of the stock market is unique. With every new IPO, investors have a new hope – maybe this next stock will give us good returns. Currently, three big names in the primary market – Amanta Healthcare, Vikran Engineering, and Anlon Healthcare – are in the limelight of investors. Their IPO GMP, i.e. Grey Market Premium, is rising rapidly and this shows a strong investor sentiment.
What is IPO GMP and why is it important?
First of all, it is important to understand that IPO GMP is an indicator that tells how much premium investors are ready to pay for a stock in the market before listing. Meaning, if the issue price of an IPO is Rs 100 and its GMP is Rs 20, then it means that investors are seeing a demand to buy it up to Rs 120. This is an unofficial market signal that gives an idea of the trend after listing.
For today’s investors, IPO GMP has become both an emotional and financial decision-making tool.
Vikran Engineering IPO GMP shows steady growth
Vikran Engineering IPO created a buzz from the day of its opening. The IPO opened on August 26 and was witnessing heavy demand from investors from the second day itself. As per NSE data, the IPO was subscribed 5 times, with a record high of just 4 times. This is a clear signal that the market has a positive sentiment about the company’s business model and valuation.
The grey market premium numbers also support this. The IPO GMP Surge has now reached 9%, which is a solid indication for investors that the stock may perform better than its issue price at the time of listing.
Anlon Healthcare IPO GMP numbers are attracting investors
If we talk about the healthcare sector, it has always been a promising sector. The Anlon Healthcare IPO, which is a Rs 121-crore issue, was 4 times subscribed by the second day of its bidding phase. This participation clearly shows that investors are bullish on the growth of the healthcare domain.
Its IPO GMP Surge is around 5% so far. It may seem a little lower than sales, but from a long-term perspective, the demand for healthcare and the growth of the sector make this IPO a safe and stable investment opportunity.
Amanta Healthcare IPO GMP surge is making investors hopeful
The most headline grabbing issue is Amanta Healthcare IPO GMP. The company manufactures sterile liquid products, including large and small volume parenterals. Its IPO will open on September 1 and the company is targeting to raise Rs 126 crore at the upper price band.
Its grey market premium has surged by 17% so far, which is an impressive number. Meaning, there is already so much interest in the market that people are ready to bid much above its issue price. This gives both an emotional and financial signal that Amanta Healthcare IPO can prove to be a blockbuster listing.
IPO GMP latest details and listing schedule
According to market trackers, the scene so far is something like this:
- Vikran Engineering IPO GMP: Price band Rs 92-97, GMP around 9%. Listing date 3 September, allotment 1 September.
- Anlon Healthcare IPO GMP: Price band Rs 86-91, GMP 5%. Listing date 3 September, allotment 1 September.
- Amanta Healthcare IPO GMP: Price band Rs 120-126, GMP 17%. Listing date 9 September, allotment 4 September.
These dates and GMP numbers clearly show that the first week of September is going to bring a blast in the IPO market for investors.
Should investors trust IPO GMP?
IPO GMP is a strong sentiment indicator but it does not mean that it gives a 100% guarantee. There are times when grey market expectations and actual listing price may differ. Hence, investors should take their decision not only on the basis of GMP but also by looking at the fundamentals, sector growth and financial health of the company.
Yes, it can definitely be said that currently IPO GMP Surge of Vikran Engineering, Anlon Healthcare and Amanta Healthcare are giving positive signals and short-term listing gains are expected.
Disclaimer:
This article is for informational purpose only. Taking investment decision on the basis of IPO GMP and market sentiments involves a risk. We suggest you to definitely take advice from your financial advisor before investing.
Also Read
Anlon Healthcare IPO Day 3 Review: GMP, Subscription Status & Should You Invest?
